Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03512197
Title A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | TUR | POL | NOR | ITA | ISR | FRA | ESP | DEU | CZE | CHE | BRA | BGR | BEL | AUT | AUS | ARG

Facility Status City State Zip Country Details
University of Chicago Medical Center . Chicago Illinois 60637 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
Oregon Health and Science Univ Portland Oregon 97239 United States Details
Novartis Investigative Site Caba Buenos Aires C1118AAT Argentina Details
Novartis Investigative Site Westmead New South Wales 2145 Australia Details
Novartis Investigative Site Woolloongabba Queensland 4102 Australia Details
Novartis Investigative Site Prahran Victoria 3181 Australia Details
Novartis Investigative Site Murdoch Western Australia 6150 Australia Details
Novartis Investigative Site Linz A-4010 Austria Details
Novartis Investigative Site Vienna 1140 Austria Details
Novartis Investigative Site Wien 1090 Austria Details
Novartis Investigative Site Antwerpen 2060 Belgium Details
Novartis Investigative Site Brugge 8000 Belgium Details
Novartis Investigative Site Roeselare 8800 Belgium Details
Novartis Investigative Site Porto Alegre RS 90035-003 Brazil Details
Novartis Investigative Site Sao Paulo SP 04014-002 Brazil Details
Novartis Investigative Site Sao Paulo 01221 900 Brazil Details
Novartis Investigative Site Sofia 1756 Bulgaria Details
Novartis Investigative Site Brno - Bohunice 625 00 Czechia Details
Novartis Investigative Site Plzen-Bory 30599 Czechia Details
Novartis Investigative Site Bayonne Bayonne Cedex 64109 France Details
Novartis Investigative Site Angers Cedex 1 49033 France Details
Novartis Investigative Site Avignon 84000 France Details
Novartis Investigative Site Dijon 21034 France Details
Novartis Investigative Site Lille Cedex 59037 France Details
Novartis Investigative Site Nantes Cedex 1 44093 France Details
Novartis Investigative Site Paris 75012 France Details
Novartis Investigative Site Pierre Benite 69495 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Regensburg Bavaria 93053 Germany Details
Novartis Investigative Site Schwerin Brandenburg 19049 Germany Details
Novartis Investigative Site Bad Saarow 15526 Germany Details
Novartis Investigative Site Berlin 10967 Germany Details
Novartis Investigative Site Berlin 12351 Germany Details
Novartis Investigative Site Berlin 13125 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Bochum 44892 Germany Details
Novartis Investigative Site Bonn 53105 Germany Details
Novartis Investigative Site Braunschweig 38114 Germany Details
Novartis Investigative Site Darmstadt 64283 Germany Details
Novartis Investigative Site Duesseldorf 40225 Germany Details
Novartis Investigative Site Duisburg 47166 Germany Details
Novartis Investigative Site Eschweiler 52249 Germany Details
Novartis Investigative Site Essen Werden 45239 Germany Details
Novartis Investigative Site Flensburg 24939 Germany Details
Novartis Investigative Site Giessen 35392 Germany Details
Novartis Investigative Site Gottingen 37075 Germany Details
Novartis Investigative Site Hamburg 20099 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Hannover 30625 Germany Details
Novartis Investigative Site Homburg 66421 Germany Details
Novartis Investigative Site Karlsruhe 76133 Germany Details
Novartis Investigative Site Kiel 24116 Germany Details
Novartis Investigative Site Leipzig 04103 Germany Details
Novartis Investigative Site Luebeck 23538 Germany Details
Novartis Investigative Site Magdeburg 39120 Germany Details
Novartis Investigative Site Mainz 55131 Germany Details
Novartis Investigative Site Muenchen 80377 Germany Details
Novartis Investigative Site Osnabrueck 49076 Germany Details
Novartis Investigative Site Paderborn 33098 Germany Details
Novartis Investigative Site Rostock 18057 Germany Details
Novartis Investigative Site Siegen 57072 Germany Details
Novartis Investigative Site Stuttgart 70176 Germany Details
Novartis Investigative Site Stuttgart 70376 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Wuerzburg 97080 Germany Details
Novartis Investigative Site Zwickau 08060 Germany Details
Novartis Investigative Site Haifa 3109601 Israel Details
Novartis Investigative Site Petach Tikva 4941492 Israel Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Alessandria AL 15100 Italy Details
Novartis Investigative Site Ancona AN 60126 Italy Details
Novartis Investigative Site Bergamo BG 24127 Italy Details
Novartis Investigative Site Brescia BS 25123 Italy Details
Novartis Investigative Site Catania CT 95123 Italy Details
Novartis Investigative Site Milano MI 20162 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Palermo PA 90146 Italy Details
Novartis Investigative Site Piacenza PC 29100 Italy Details
Novartis Investigative Site Pescara PE 65124 Italy Details
Novartis Investigative Site Perugia PG 06129 Italy Details
Novartis Investigative Site Reggio Calabria RC 89124 Italy Details
Novartis Investigative Site Roma RM 00133 Italy Details
Novartis Investigative Site Roma RM 00161 Italy Details
Novartis Investigative Site Roma RM 00168 Italy Details
Novartis Investigative Site Taranto TA 74100 Italy Details
Novartis Investigative Site Torino TO 10126 Italy Details
Novartis Investigative Site Vicenza VI 36100 Italy Details
Novartis Investigative Site Nagoya-city Aichi 466-8650 Japan Details
Novartis Investigative Site Matsuyama-city Ehime 790-8524 Japan Details
Novartis Investigative Site Fukuoka city Fukuoka 812-8582 Japan Details
Novartis Investigative Site Fukushima city Fukushima 960 1295 Japan Details
Novartis Investigative Site Gifu shi Gifu 500 8513 Japan Details
Novartis Investigative Site Fukuyama Hiroshima 720-0001 Japan Details
Novartis Investigative Site Tsukuba city Ibaraki 305-8576 Japan Details
Novartis Investigative Site Isehara Kanagawa 259-1193 Japan Details
Novartis Investigative Site Nagasaki-city Nagasaki 852-8501 Japan Details
Novartis Investigative Site Okayama city Okayama 701-1192 Japan Details
Novartis Investigative Site Hirakata-city Osaka 573-1191 Japan Details
Novartis Investigative Site Osaka Sayama Osaka 589 8511 Japan Details
Novartis Investigative Site Hamamatsu Shizuoka 432-8580 Japan Details
Novartis Investigative Site Shimotsuke Tochigi 329-0498 Japan Details
Novartis Investigative Site Bunkyo ku Tokyo 113-8677 Japan Details
Novartis Investigative Site Bunkyo-ku Tokyo 113-8603 Japan Details
Novartis Investigative Site Aomori 030 8553 Japan Details
Novartis Investigative Site Kyoto 606 8507 Japan Details
Novartis Investigative Site Osaka 534-0021 Japan Details
Novartis Investigative Site Yamagata 990 9585 Japan Details
Novartis Investigative Site Bergen NO-5021 Norway Details
Novartis Investigative Site Oslo 0424 Norway Details
Novartis Investigative Site Gdansk 80 952 Poland Details
Novartis Investigative Site Lisboa 1099 023 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Cordoba Andalucia 14004 Spain Details
Novartis Investigative Site Sevilla Andalucia 41013 Spain Details
Novartis Investigative Site Salamanca Castilla Y Leon 37007 Spain Details
Novartis Investigative Site Hospitalet de LLobregat Catalunya 08907 Spain Details
Novartis Investigative Site Caceres Extremadura 10003 Spain Details
Novartis Investigative Site Barakaldo Pais Vasco 48903 Spain Details
Novartis Investigative Site Barcelona 08041 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Valencia 46026 Spain Details
Novartis Investigative Site Zaragoza 50009 Spain Details
Novartis Investigative Site Bern 3010 Switzerland Details
Novartis Investigative Site Zurich 8091 Switzerland Details
Novartis Investigative Site Putzu City Chiayi Hsien 61363 Taiwan Details
Novartis Investigative Site Kuei Shan Chiang Taoyuan Taiwan ROC 33305 Taiwan Details
Novartis Investigative Site Kaohsiung City 83301 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Adana 01330 Turkey Details
Novartis Investigative Site Ankara 06100 Turkey Details
Novartis Investigative Site Aydin 09100 Turkey Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field